University of Pittsburgh.
Chatham University.
West J Emerg Med. 2024 May;25(3):431-435. doi: 10.5811/westjem.18396.
Ectopic pregnancies are a significant cause of morbidity and mortality in the first trimester of pregnancy. Hospital protocols requiring a specific beta-human chorionic gonadotropin (β-hCG) level to qualify for diagnostic testing (pelvic ultrasound) can delay diagnosis and treatment. In this study we sought to determine the relationship between β-hCG level and the size of ectopic pregnancy with associated outcomes.
We performed a retrospective case review of patients diagnosed with ectopic pregnancy in an urban, academic emergency department specializing in obstetrical care, from January 1, 2015-December 31, 2017. Variables extracted included presentation, treatment, adverse outcomes, and rates of rupture.
We identified 519 unique ectopic pregnancies. Of those ectopic pregnancies, 22.9% presented with evidence of rupture on ultrasound, and 14.4% showed evidence of hemodynamic instability (pulse >100 beats per minute; systolic blood pressure <90 millimeters of mercury; or evidence of significant blood loss) on presentation. Medical management outcomes were as follows: of 177 patients who received single-dose methotrexate, 14.7% failed medical management and required surgical intervention; of 46 who received multi-dose methotrexate, 36.9% failed medical management and required surgical intervention. Ultimately, 55.7% of patients required operative management of their ectopic pregnancy. Mean β-hCG level at initial presentation was 7,096 milli-international units per milliliter (mIU/mL) (SD 88,872 mIU/mL) with a median of 1,289 mIU/mL; 50.4% of ectopic pregnancies presented with β-hCG levels less than the standard discriminatory zone of 1,500 mIU/mL. Additionally, 44% of the patients who presented with evidence of rupture had β-hCG levels less than 1,500 mIU/mL. Comparison of size of ectopic pregnancy (based on maximum dimension in millimeters) to β-hCG levels revealed a very weak correlation (r = 0.144, ), and detection of ectopic pregnancies by ultrasound was independent of β-hCG levels.
Levels of β-hCG do not correlate with the presence or size of an ectopic pregnancy, indicating need for diagnostic imaging regardless of β-hCG level in patients with clinical suspicion for ectopic pregnancy. Almost one-sixth of patients presented with evidence of hemodynamic instability, and approximately one quarter of patients presented with evidence of rupture requiring emergent operative management. Ultimately, more than half of patients required an operative procedure to definitively manage their ectopic pregnancy.
异位妊娠是妊娠早期导致发病率和死亡率的重要原因。医院的诊疗方案要求β-人绒毛膜促性腺激素(β-hCG)水平达到特定标准,才能进行诊断性检查(盆腔超声),这可能会延误诊断和治疗。本研究旨在确定β-hCG 水平与异位妊娠大小之间的关系及其与相关结局的关系。
我们对 2015 年 1 月 1 日至 2017 年 12 月 31 日在一家专门从事产科护理的城市学术急诊室中诊断为异位妊娠的患者进行了回顾性病例分析。提取的变量包括临床表现、治疗方法、不良结局和破裂率。
我们共发现 519 例异位妊娠。其中,22.9%的患者在超声检查中显示有破裂的证据,14.4%的患者在就诊时表现出血流动力学不稳定(脉搏>100 次/分钟;收缩压<90 毫米汞柱;或有明显失血的证据)。药物治疗结局如下:177 例接受单次甲氨蝶呤治疗的患者中,14.7%的患者药物治疗失败,需要手术干预;46 例接受多剂量甲氨蝶呤治疗的患者中,36.9%的患者药物治疗失败,需要手术干预。最终,55.7%的患者需要手术治疗异位妊娠。初次就诊时β-hCG 水平的平均值为 7096 毫国际单位/毫升(SD 88872 mIU/mL),中位数为 1289 mIU/mL;50.4%的异位妊娠患者的β-hCG 水平低于 1500 mIU/mL 的标准鉴别区。此外,44%有破裂证据的患者的β-hCG 水平低于 1500 mIU/mL。将异位妊娠的大小(以毫米为单位的最大直径)与β-hCG 水平进行比较,发现两者相关性非常弱(r=0.144,),超声检查发现异位妊娠与β-hCG 水平无关。
β-hCG 水平与异位妊娠的存在或大小无关,这表明在疑似异位妊娠的患者中,无论β-hCG 水平如何,都需要进行诊断性影像学检查。近六分之一的患者表现出血流动力学不稳定的证据,约四分之一的患者表现出破裂的证据,需要紧急手术治疗。最终,超过一半的患者需要手术来明确治疗他们的异位妊娠。